INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
TC
Tarvin Landon CPresident,UFP Retail Solutions
UFPIUFP INDUSTRIES INC
Grant or award
A$1,105
12 sh
Mar 31, 2026Apr 1, 2026
Page 1032 of 1737
← PrevNext →
traded Mar 31, 2026
+1d
SEC Form 4

Evidence

9
CR
Clark RichardDirector
MMacy's, Inc.
Grant or award
A$27K
1,366 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

9
GP
Gipson William PDirector
ROKROCKWELL AUTOMATION, INC
Grant or award
A—
90 sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC Form 4

Evidence

9
DE
Deitzel EdwardEVP, CRO, CCO MIAX Exchanges
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Tax withholding
F$27K
707 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

9
BS
Brown ShellyEVP, Chief Strategy Officer
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Option exercise
M—
5,040 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

9
SR
Savitz RyanEVP, CFO & CBO
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$65K
800 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

9
SJ
Sumner Michael JohnChief Medical Officer
INOINOVIO PHARMACEUTICALS, INC.
Tax withholding
F$2,128
1,223 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

9
WM
Weakley MonicaDirector
EXPIAGNT, Inc.
Grant or award
A—
58 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

9
JD
Jin DavidChief Financial Officer
FBIOFortress Biotech, Inc.
Grant or award
A$6,456
2,967 sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC Form 4

Evidence

9
CC
Cochran CarolineDirector, Co-Founder, COO, 10% Owner
OKLOOklo Inc.
Other acquisition or disposition
J—
474.0K sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

9
BN
Ballew NealCHIEF ACCOUNTING OFFICER
OHIOMEGA HEALTHCARE INVESTORS INC
Option exercise
M—
5,620 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

9
VE
Vougessis EvangelineDirector
HTZHERTZ GLOBAL HOLDINGS, INC
Grant or award
A$13K
2,712 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

9
US
Upshaw Jennifer SpinksChief Administrative Officer
PNFPPinnacle Financial Partners, Inc.
Tax withholding
F$251
3 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

9
BS
Brown ShellyEVP, Chief Strategy Officer
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Option exercise
M—
8,333 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

9
CS
Creson ShellieChief Risk Officer
PNFPPinnacle Financial Partners, Inc.
Tax withholding
F$334
4 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

9
GV
Gupta VikasChief Investment Officer
OHIOMEGA HEALTHCARE INVESTORS INC
Option exercise
M—
14.9K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

9
SR
Savitz RyanEVP, CFO & CBO
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$109K
1,390 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

9
BZ
Bishop Daniel ZacharyChief Operating Officer
PNFPPinnacle Financial Partners, Inc.
Tax withholding
F$585
7 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

9
CC
Cochran CarolineDirector, Co-Founder, COO, 10% Owner
OKLOOklo Inc.
Other acquisition or disposition
J—
506.8K sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

9
DJ
DeWitte JacobDirector, Co-Founder, CEO, 10% Owner
OKLOOklo Inc.
Other acquisition or disposition
J—
474.0K sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

9
KI
Kaul InderjitDirector
NERVMinerva Neurosciences, Inc.
Grant or award
A—
12.2K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

9
SJ
Smollen JohnEVP, New Product Development
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Tax withholding
F$14K
362 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

9
PD
Porteous William D.Director
BKSYBlackSky Technology Inc.
Grant or award
A—
894 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

9
SB
Slotkin BryanDirector
ESTAESTABLISHMENT LABS HOLDINGS INC.
Grant or award
A$16K
286 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

9
SW
Sesler Douglas WilliamDirector
MMacy's, Inc.
Grant or award
A$27K
1,366 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

9
HA
Huang Claire ADirector
ZIONZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/
Grant or award
A$30K
549 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

9
SR
Steele William Robert JrChief Financial Officer
USARUSA Rare Earth, Inc.
Grant or award
A—
63.5K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

9
JA
Jain AshishCTO
OSPNOneSpan Inc.
Grant or award
A—
43.0K sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

9
BS
Brown ShellyEVP, Chief Strategy Officer
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Option exercise
M—
3,878 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

9
GP
Gourmand Matthew PaulPresident
OHIOMEGA HEALTHCARE INVESTORS INC
Option exercise
M—
5,620 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

9
GP
Gourmand Matthew PaulPresident
OHIOMEGA HEALTHCARE INVESTORS INC
Option exercise
M—
5,620 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

9
BS
Brown ShellyEVP, Chief Strategy Officer
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Option exercise
M—
6,570 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

9
BN
Ballew NealCHIEF ACCOUNTING OFFICER
OHIOMEGA HEALTHCARE INVESTORS INC
Disposition to issuer
D$351
8 sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC Form 4

Evidence

8
BC
Bird Justin ChristopherExecutive Vice President
SRESEMPRA
Open-market sale · 10b5-1 plan
SELL$109K
1,128 sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC Form 4

Evidence

8
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$37K
4,000 sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC Form 4

Evidence

7
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$78K
7,500 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

7
SR
Savitz RyanEVP, CFO & CBO
DNTHDianthus Therapeutics, Inc. /DE/
Option exercise · 10b5-1 plan
M—
40.0K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

6
ND
Noci DarleneChief Development Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M$153K
5,500 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

5
CC
Cochran CarolineDirector, Co-Founder, COO, 10% Owner
OKLOOklo Inc.
Other acquisition or disposition
J—
474.0K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

5
FC
Fang ChenDirector, Chief Revenue Officer
BTGOBITGO HOLDINGS, INC.
Grant or award
A—
21.7K sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence